General Information of the Compound
| Compound ID |
CP0224339
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
ARRY-520
Show/Hide
|
||||||||||||||||||
| Synonyms |
(2S)-2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3(2H)-carboxamide
1385020-40-5
3452AH
885060-09-3
8A49OSO368
AKOS030526964
ARRY 520
ARRY 520 trifluoroacetate
ARRY-520
Arry520
BCP07442
BDBM50431893
C20H22F2N4O2S
CHEMBL2347655
CS-0867
DTXSID50237086
EX-A678
Filanesib
Filanesib [INN]
Filanesib [USAN:INN]
Filanesib(ARRY-520)
NCGC00381751-02
NCGC00381751-04
RL05514
SB19209
SCHEMBL368043
UNII-8A49OSO368
ZINC43204022
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H22F2N4O2S
|
||||||||||||||||||
| Molecular Weight |
420.485
|
||||||||||||||||||
| Canonical SMILES |
CON(C)C(=O)N1N=C(S[C@@]1(CCCN)c1ccccc1)c1cc(F)ccc1F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H22F2N4O2S/c1-25(28-2)19(27)26-20(11-6-12-23,14-7-4-3-5-8-14)29-18(24-26)16-13-15(21)9-10-17(16)22/h3-5,7-10,13H,6,11-12,23H2,1-2H3/t20-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
LLXISKGBWFTGEI-FQEVSTJZSA-N
|
||||||||||||||||||
| CAS |
885060-09-3
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Clinical Information about the Compound